Administration units comprising polymorph 1 of 2-(2-methylamino-pyrimidin-4-yl]-1h-indole-5-carboxylic acid [(s)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide
作者： Frank Trinius
DOI:
关键词:
摘要: The invention relates to a packaging comprising one or more administration units sodium salt of (R)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexyl-1H-imidazol-4-yl)-propionic acid.
lens.org参考文章(49)
Marc-Antoine Perrin, Stéphane Mutti, Joel Malpart, Novel crystal form of (2s)-2-amino-3-hydroxy-n-[2-methoxy-2-[(1z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]propanamide and method of preparation thereof ,(2012)
Nicolas Tremaudeux, Eric Didier, Pascal Besse, Combretastatin derivative preparation method ,(2010)
Beverly Nickerson, Properties That Impact Sample Preparation and Extraction of Pharmaceutical Dosage Forms Springer, Boston, MA. pp. 3- 19 ,(2011) , 10.1007/978-1-4419-9631-2_1
Markus Kohlmann, Gerhard Hessler, Gernot Zech, Marc Nazaré, Melitta Just, Tilo Weiss, Heterocyclic pyrazole-carboxamides as p2y12 antagonists ,(2008)
Jörg Schwedes, Dietmar Schulze, Powders and bulk solids : behavior, characterization, storage and flow Springer Verlag. ,(2008)
Kai Rossen, Hermut Wehlan, Antony Bigot, Véronique Crocq-Stuerga, Volker Kraft, Process for the preparation of a compound useful as an inhibitor of tafia ,(2010)
Stéphane Mutti, Michel Lavigne, Jean-Paul Casimir, Irina Malejonock, Method for preparing combretastatins ,(2003)
Adolf Linkies, Guenter Billen, Tobias Metzenthin, Joachim Graeser, Method for producing 2-(2-aminopyrimidin-4-yl)-1H-indole-5-carboxylic acid derivatives ,(2006)
Stephane Mutti, Sylviane Lutz, Marc Frederic, Joel Malpart, Philippe Masson, Method for preparing combretastatin ,(2009)
S. Lowell, Joan E. Shields, Martin A. Thomas, Matthians Thommes, Characterization of Porous Solids and Powders: Surface Area, Pore Size and Density ,(2004)